Life Length

Bensalem, United States Founded: 2010 • Age: 16 yrs
Provides telomere length analysis technology for diagnosis
Request Access

About Life Length

Life Length is a company based in Bensalem (United States) founded in 2010 by Stephen J Matlin.. Life Length has raised $2.7 million across 6 funding rounds from investors including European Union, EMPLEO COMUNIDAD DE MADRID and EIC Fund. Life Length offers products and services including HealthTAV, HealthNAD+, and HealthOX. Life Length operates in a competitive market with competitors including Metabolon, Maze Therapeutics, Seer, Alector and Scailyte, among others.

  • Headquarter Bensalem, United States
  • Founders Stephen J Matlin
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Services & Infrastructure
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.7 M (USD)

    in 6 rounds

  • Latest Funding Round
    $2.12 M (USD), Grant

    Jan 11, 2024

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Life Length

Life Length offers a comprehensive portfolio of products and services, including HealthTAV, HealthNAD+, and HealthOX. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Assesses cellular health and biological age through telomere analysis

Measures NAD+ levels to evaluate cellular energy and aging risks

Analyzes oxidative stress as a key health and metabolism indicator

People of Life Length
Headcount 10-50
Employee Profiles 11
Board Members and Advisors 2
Employee Profiles
People
Stephen J. Matlin
CEO
People
Rocío Núñez
Clinical Pathology Manager
People
Enrique Segovia
CTO & Operations Director
People
Mónica Parramón
Senior Clinical & Market Access Director

Unlock access to complete

Board Members and Advisors
people
Juan Pablo Rodríguez Castejón
Chairman
people
Inderjeet Dokal
Scientific Advisor

Unlock access to complete

Funding Insights of Life Length

Life Length has successfully raised a total of $2.7M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $2.12 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Grant — $2.1M
  • First Round

    (01 Sep 2015)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2024 Amount Grant - Life Length Valuation

investors

Jul, 2019 Amount Seed - Life Length Valuation

investors

Dec, 2018 Amount Grant - Life Length Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Life Length

Life Length has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, EMPLEO COMUNIDAD DE MADRID and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Public services and information are provided for Madrid citizens.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Life Length

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Life Length

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Life Length Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Life Length

Life Length operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Metabolon, Maze Therapeutics, Seer, Alector and Scailyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Solutions for biomarker discovery and diagnostic testing are provided.
domain founded_year HQ Location
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
domain founded_year HQ Location
Proteomics platform developed for early cancer and neurological disease detection.
domain founded_year HQ Location
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
domain founded_year HQ Location
Single-cell data is analyzed via AI for biomarker discovery.
domain founded_year HQ Location
NeoPhore is focused on cancer neoantigen evolution therapies.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Life Length

Frequently Asked Questions about Life Length

When was Life Length founded?

Life Length was founded in 2010 and raised its 1st funding round 5 years after it was founded.

Where is Life Length located?

Life Length is headquartered in Bensalem, United States. It is registered at Bensalem, Pennsylvania, United States.

Who is the current CEO of Life Length?

Stephen J Matlin is the current CEO of Life Length. They have also founded this company.

Is Life Length a funded company?

Life Length is a funded company, having raised a total of $2.7M across 6 funding rounds to date. The company's 1st funding round was a Grant of $3.56M, raised on Sep 01, 2015.

What does Life Length do?

Provides telomere length analysis technology for diagnosis. The company offers its proprietary technology for telomerase length detection for the health and aging process. It offers its services to physicians, individuals, researchers, and corporations. The company is involved in the development of biomarkers and its flagship product ONCOCHECK for clinical validation of Telomere Associated Variables (TAVs) as cancer biomarkers by its TAT technology for prostate cancer.

Who are the top competitors of Life Length?

Life Length's top competitors include Alector, Maze Therapeutics and Metabolon.

What products or services does Life Length offer?

Life Length offers HealthTAV, HealthNAD+, and HealthOX.

Who are Life Length's investors?

Life Length has 3 investors. Key investors include European Union, EMPLEO COMUNIDAD DE MADRID, and EIC Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available